Pediatric Nephrology

, Volume 24, Issue 3, pp 555–563

Progression of coronary calcification in pediatric chronic kidney disease stage 5

  • Mahmut Civilibal
  • Salim Caliskan
  • Sebuh Kurugoglu
  • Cengiz Candan
  • Nur Canpolat
  • Lale Sever
  • Ozgur Kasapcopur
  • Nil Arisoy
Original Article


Coronary artery calcification (CAC) is common in adults with chronic kidney disease (CKD) and progresses with time. However, data are limited for younger patients. We have previously reported CAC in eight of 53 children with CKD. After 2 years, CAC evaluation was repeated in 48 patients. The median CAC score (CACS) increased from 101.3 (1473.6 ± 1978.6, range 8.5–4332) to 1759.2 (2236.4 ± 2463.3, range 0–5858) Agatston units (AU). When the individual changes in CACS were evaluated one by one, we showed a mild decrease in two patients on hemodialysis (HD) and in one transplant (Tx) recipient, a moderate increase in one patient on HD, one on peritoneal dialysis (PD) and one Tx recipient, and a large increase in one HD patient. Also, CAC disappeared in one HD patient. All patients with no calcification at baseline remained calcification-free at follow-up. To obtain the individual cumulative exposure, we calculated time-averaged mean values, using the laboratory values from the beginning of dialysis to the first and second multidetector spiral computed tomography (MDCT) scans (baseline and final values, respectively). Final CACS was positively related to final calcium–phosphorus (Ca×P) product, while CAC progression was inversely associated with final serum albumin level. This report is the first study with the largest number and the youngest cohort to document the natural history of coronary calcification.


Child Young adult Coronary artery calcification Chronic kidney disease Dialysis Transplantation 


  1. 1.
    Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 [Suppl 12]:S16–S23PubMedGoogle Scholar
  2. 2.
    Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 432:1478–1483CrossRefGoogle Scholar
  3. 3.
    Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Grönemeyer D (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892–1894PubMedCrossRefGoogle Scholar
  4. 4.
    Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105PubMedCrossRefGoogle Scholar
  5. 5.
    Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906–1914PubMedCrossRefGoogle Scholar
  6. 6.
    Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996–3003PubMedCrossRefGoogle Scholar
  7. 7.
    Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426–1433PubMedCrossRefGoogle Scholar
  8. 8.
    Moe SM, O’Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA (2004) Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 19:2387–2393PubMedCrossRefGoogle Scholar
  9. 9.
    Stompor T, Pasowicz M, Sulowicz W, Dembinska-Kiec A, Tracz W (2004) Trends in coronary artery calcification in peritoneal dialysis and transplant patients. Nephrol Dial Transplant 19:3205–3206PubMedCrossRefGoogle Scholar
  10. 10.
    Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64–69PubMedCrossRefGoogle Scholar
  11. 11.
    Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245–252PubMedCrossRefGoogle Scholar
  12. 12.
    Asmus HG, Braun J, Krause R, Brunkhorst R, Holzer H, Schulz W, Neumayer HH, Raggi P, Bommer J (2005) Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 20:1653–1661PubMedCrossRefGoogle Scholar
  13. 13.
    Jung HH, Kim SW, Han H (2006) Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 21:1915–1920PubMedCrossRefGoogle Scholar
  14. 14.
    Yuen D, Pierratos A, Richardson RM, Chan CT (2006) The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 21:1407–1412PubMedCrossRefGoogle Scholar
  15. 15.
    De Lima JJ, Vieira ML, Viviani LF, Medeiros CJ, Ianhez LE, Kopel L, de Andrade JL, Krieger EM, Lage SG (2002) Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 17:645–651PubMedCrossRefGoogle Scholar
  16. 16.
    Litwin M, Wühl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F (2008) Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552–2557PubMedCrossRefGoogle Scholar
  17. 17.
    Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Paediatr 95:194–198PubMedCrossRefGoogle Scholar
  18. 18.
    Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832PubMedCrossRefGoogle Scholar
  19. 19.
    London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731–1740PubMedCrossRefGoogle Scholar
  20. 20.
    Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S (2004) Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8:54–58PubMedCrossRefGoogle Scholar
  21. 21.
    Mitsnefes MM (2008) Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol 23:27–39PubMedCrossRefGoogle Scholar
  22. 22.
    Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20:760–767PubMedCrossRefGoogle Scholar
  23. 23.
    Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307–2312PubMedCrossRefGoogle Scholar
  24. 24.
    Moe SM, O’Neill KD, Fineberg N, Persohn S, Ahmed S, Garret P, Meyer CA (2003) Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 18:1152–1158PubMedCrossRefGoogle Scholar
  25. 25.
    Qunibi WY (2005) Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. J Am Soc Nephrol 16 [Suppl 2]:S95–S102PubMedCrossRefGoogle Scholar
  26. 26.
    Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N, Vascular Calcification Work Group (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572–579PubMedCrossRefGoogle Scholar
  27. 27.
    Salusky IB, Goodman WG (2000) Managing phosphate retention: is a change necessary? Nephrol Dial Transplant 15:1738–1742PubMedCrossRefGoogle Scholar
  28. 28.
    Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931–936PubMedCrossRefGoogle Scholar
  29. 29.
    Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263–3271PubMedCrossRefGoogle Scholar
  30. 30.
    Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494–1500PubMedCrossRefGoogle Scholar
  31. 31.
    Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179–184PubMedCrossRefGoogle Scholar
  32. 32.
    Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115–1125PubMedCrossRefGoogle Scholar
  33. 33.
    Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858–1865PubMedCrossRefGoogle Scholar
  34. 34.
    Tentori F (2007) Focus on vitamin D therapy in chronic kidney disease. J Nephrol 20:511–514PubMedGoogle Scholar
  35. 35.
    Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446–456PubMedCrossRefGoogle Scholar
  36. 36.
    Wolf M, Thadhani R (2007) Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol 103:487–490PubMedCrossRefGoogle Scholar
  37. 37.
    London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613–620PubMedCrossRefGoogle Scholar
  38. 38.
    Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239–1246PubMedCrossRefGoogle Scholar
  39. 39.
    McCullough PA (2005) Effect of lipid modification on progression of coronary calcification. J Am Soc Nephrol 16 [Suppl 2]:S115–S119PubMedCrossRefGoogle Scholar
  40. 40.
    Chertow GM (2003) Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 14 [Suppl 4]:S310–S314PubMedCrossRefGoogle Scholar
  41. 41.
    Oschatz E, Benesch T, Kodras K, Hoffmann U, Haas M (2006) Changes of coronary calcification after kidney transplantation. Am J Kidney Dis 48:307–313PubMedCrossRefGoogle Scholar
  42. 42.
    Schankel K, Robinson J, Bloom RD, Guerra C, Rader D, Joffe M, Rosas SE (2007) Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant 7:2158–2164PubMedCrossRefGoogle Scholar
  43. 43.
    Ligtenberg G, Hene RJ, Blankestijn PJ, Koomans HA (2001) Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol 12:368–373PubMedGoogle Scholar
  44. 44.
    Oflaz H, Turkmen A, Kazancioglu R, Kayacan SM, Bunyak B, Genchallac H, Erol B, Mercanoglu F, Umman S, Sever MS (2003) The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 17:212–216PubMedCrossRefGoogle Scholar
  45. 45.
    Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB (2003) Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. J Am Soc Nephrol 14:1880–1888PubMedCrossRefGoogle Scholar
  46. 46.
    Schmermund A, Baumgart D, Möhlenkamp S, Kriener P, Pump H, Grönemeyer D, Seibel R, Erbel R (2001) Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 21:421–426PubMedGoogle Scholar
  47. 47.
    Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339:1972–1978PubMedCrossRefGoogle Scholar
  48. 48.
    Sigrist MK, Taal MW, Bungay P, McIntyre CW (2007) Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241–1248PubMedCrossRefGoogle Scholar
  49. 49.
    Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK (2004) Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489–1496PubMedCrossRefGoogle Scholar
  50. 50.
    Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y (2004) Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. Am J Clin Nutr 80:1536–1543PubMedGoogle Scholar
  51. 51.
    Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936PubMedGoogle Scholar
  52. 52.
    Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203–211PubMedCrossRefGoogle Scholar
  53. 53.
    Tonbul HZ, Demir M, Altintepe L, Güney I, Yeter E, Türk S, Yeksan M, Yildiz A (2006) Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail 28:287–294PubMedCrossRefGoogle Scholar
  54. 54.
    Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, Gullulu M (2008) Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 108:99–105CrossRefGoogle Scholar

Copyright information

© IPNA 2008

Authors and Affiliations

  • Mahmut Civilibal
    • 1
    • 3
  • Salim Caliskan
    • 1
  • Sebuh Kurugoglu
    • 2
  • Cengiz Candan
    • 1
  • Nur Canpolat
    • 1
  • Lale Sever
    • 1
  • Ozgur Kasapcopur
    • 1
  • Nil Arisoy
    • 1
  1. 1.Department of Pediatric NephrologyIstanbul University Cerrahpasa Medical FacultyIstanbulTurkey
  2. 2.Department of RadiologyIstanbul University Cerrahpasa Medical FacultyIstanbulTurkey
  3. 3.Atakoy 7–8.kısımMimar Sinan SitesiIstanbulTurkey

Personalised recommendations